Sandbox:Hannan: Difference between revisions

Revision as of 12:17, 15 January 2019


Myeloproliferative neoplasms (MPN)	Clinical manifestations		Diagnosis
Myeloproliferative neoplasms (MPN)	Symptoms	Physical examination	Laboratory Findings	Bone Marrow Biopsy	Gold Standard	Others
Chronic myeloid leukemia (CML), BCR-ABL1+
Chronic neutrophilic leukemia (CNL)
Polycythemia vera (PV)
Primary myelofibrosis (PMF) prefibrotic/early stage overt fibrotic stage
Essential thrombocythemia (ET)
Chronic eosinophilic leukemia, not otherwise specified (NOS)
MPN, unclassifiable
Mastocytosis

Clinical manifestations

Symptoms

Physical examination

Myeloid/lymphoid neoplasms with eosinophilia and rearrangement of

PDGFRA, PDGFRB ,or FGFR1, or with PCM1-JAK2

Myelodysplastic/myeloproliferative neoplasms (MDS/MPN)

Myelodysplastic syndromes (MDS)

Acute myeloid leukemia (AML) and related neoplasms

Blastic plasmacytoid dendritic cell neoplasm

Acute leukemias of ambiguous lineage

B-lymphoblastic leukemia/lymphoma

T-lymphoblastic leukemia/lymphoma

@@ Line 6: / Line 6: @@
 ! colspan="2" |Clinical manifestations
 ! colspan="4" |Diagnosis
+!Other Features
 |-
 !Symptoms
@@ Line 13: / Line 14: @@
 !Gold Standard
 !Others
+!
 |-
 |Chronic myeloid leukemia
 (CML), BCR-ABL1+
+|
 |
 |
@@ Line 25: / Line 28: @@
 |-
 |Chronic neutrophilic leukemia (CNL)
+|
 |
 |
@@ Line 33: / Line 37: @@
 |-
 |Polycythemia vera (PV)
+|
 |
 |
@@ Line 43: / Line 48: @@
 * prefibrotic/early stage
 * overt fibrotic stage
+|
 |
 |
@@ Line 51: / Line 57: @@
 |-
 |Essential thrombocythemia (ET)
+|
 |
 |
@@ Line 59: / Line 66: @@
 |-
 |Chronic eosinophilic leukemia, not otherwise specified (NOS)
+|
 |
 |
@@ Line 67: / Line 75: @@
 |-
 |MPN, unclassifiable
+|
 |
 |
@@ Line 75: / Line 84: @@
 |-
 |Mastocytosis
+|
 |
 |